MEDNAX, Inc. [MD] took an upward turn with a change of 2.09%, trading at the price of $25.91 during the trading session on . The price movement in correlation with percentage of the mentioned increase can allow a valuable insight to investors. During the last trading session 1.51 million shares changed hands being bought and sold, while MEDNAX, Inc. shares have an average trading volume of 1.16M shares for that time period. MD monthly volatility recorded 2.32%, in the meanwhile having share price volatility for the week set at 1.79%. PS value for MD stocks is 0.60 with PB recorded at 1.44.

MEDNAX, Inc. [NYSE:MD]: Analyst Rating and Earnings

Its stock price has been found in the range of 19.93 to 39.96. This is compared to its latest closing price of $25.38.

Keep your eyes peeled for the next scheduled financial results to be made public for this company, which are scheduled to be released on Thu 6 Feb (In 60 Days).

Fundamental Analysis of MEDNAX, Inc. [MD]

Now let’s turn to look at profitability: with a current Operating Margin for MEDNAX, Inc. [MD] sitting at +12.22 and its Gross Margin at +24.08, this company’s Net Margin is now -40.90%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.

This company’s Return on Total Capital is 8.93, and its Return on Invested Capital has reached 6.80%. Its Return on Equity is 8.73, and its Return on Assets is 4.55. These metrics suggest that this MEDNAX, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

Turning to investigate th

is organization’s capital structure, MEDNAX, Inc. [MD] has generated a Total Debt to Total Equity ratio of 63.94. Similarly, its Total Debt to Total Capital is 39.00, while its Total Debt to Total Assets stands at 33.27. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 5.02, and its Long-Term Debt to Total Capital is 63.94.

What about valuation? This company’s Enterprise Value to EBITDA is 7.32 and its Total Debt to EBITDA Value is 3.54. The Enterprise Value to Sales for this firm is now 1.15, and its Total Debt to Enterprise Value stands at 0.40. MEDNAX, Inc. [MD] has a Price to Book Ratio of 0.94, a Price to Cash Flow Ratio of 10.43.

Shifting the focus to workforce efficiency, MEDNAX, Inc. [MD] earns $226,741 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 6.97 and its Total Asset Turnover is 0.62. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.31 and its Current Ratio is 1.31. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

MEDNAX, Inc. [MD] has 82.57M shares outstanding, amounting to a total market cap of $2.14B. Its stock price has been found in the range of 19.93 to 39.96. At its current price, it has moved down by -35.15% from its 52-week high, and it has moved up 30.01% from its 52-week low.

This stock’s Beta value is currently 0.76, which indicates that it is 1.79% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 55.95. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is MEDNAX, Inc. [MD] a Reliable Buy?

Shares of MEDNAX, Inc. [MD], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.